Frequently identified genetic alterations in osteosarcoma and MFH are p53 and Rb mutation, MDM2 amplification, loss of function of p16, and CDK4-cyclinD amplification. This evidence concerns the gene TP53 and undifferentiated pleomorphic sarcoma.